Notable Dexcom Insider Makes $10.22 Million Sale

Quentin S Blackford, Chief Operating Officer at Dexcom (NASDAQ:DXCM), made a large insider sell on September 10, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Blackford sold 18,662 shares of Dexcom at a price of $546.7 per share. The total transaction amounted to $10,219,648.

Blackford still owns a total of 19,280 of Dexcom worth, $10,592,046.

Dexcom shares were down 0.59% after Friday's closing.

The Importance of Insider Transactions

Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Transaction Codes To Focus On

Check Out The Full List Of Dexcom's Insider Trades.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.